• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Acrosome formation-associated factor (AFAF), Truncated

ACP11216

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11216 Target NameEQTN
Target SynonymsAcrosome formation-associated factor; Afaf; AFAF_HUMAN; C9orf11; chromosome 9 open reading frame 11 ; equatorinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NQ60
Background Information
  • Uniprot Id

    Q9NQ60

  • Target Species

    Human

  • Target Name

    EQTN

  • Target Full Name

    Equatorin

  • Target Function

    Acrosomal membrane-anchored protein involved in the process of fertilization and in acrosome biogenesis.

  • Target Subcellular Location

    Cytoplasmic vesicle, secretory vesicle, acrosome membrane; Single-pass type I membrane protein. Cytoplasmic vesicle, secretory vesicle, acrosome inner membrane; Single-pass type I membrane protein. Cytoplasmic vesicle, secretory vesicle, acrosome outer membrane; Single-pass type I membrane protein.

  • Target Tissue Specificity

    Isoform 1 is highly expressed in testis. Isoform 2 is expressed at low levels in skin and blood.

  • Target Synonyms

    Acrosome formation-associated factor; Afaf; AFAF_HUMAN; C9orf11; chromosome 9 open reading frame 11 ; equatorin

Inquire Recombinant Human Acrosome formation-associated factor (AFAF), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification